Related Experiment Video
Updated: Jan 25, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
Vaccine Therapies for Breast Cancer
Erin E Burke1, Krithika Kodumudi2, Ganesan Ramamoorthi2
1H. Lee Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.
Abstract:
Vaccines can be a cost effective preventive measure for both primary prevention of disease and prevention of disease recurrence. Several vaccines targeting breast cancer oncodrivers are currently being tested in clinical trials. Whereas clinical response rates to breast cancer vaccines have been modest despite the induction of strong antitumor T cell responses, it is through these approaches that valuable insight and knowledge have been gained about tumor immunology. With the emergence of new immunotherapies, there is renewed excitement for effective breast cancer vaccine development.
Insights
Breast cancer vaccines show promise for preventing disease recurrence. Despite modest clinical responses, ongoing research and new immunotherapies are fueling excitement for developing effective breast cancer vaccines.
Area of Science:
- Oncology
- Immunology
- Vaccinology
Background:
- Vaccines offer cost-effective disease prevention and recurrence prevention.
- Several breast cancer vaccines targeting oncodrivers are in clinical trials.
- Current breast cancer vaccines induce antitumor T-cell responses but show modest clinical efficacy.
Purpose of the Study:
- To review the current landscape of breast cancer vaccine development.
- To highlight insights gained from tumor immunology through vaccine trials.
- To discuss the renewed potential for breast cancer vaccines with emerging immunotherapies.
Main Methods:
- Review of clinical trial data for breast cancer vaccines.
- Analysis of immunological responses to breast cancer vaccines.
- Assessment of the impact of new immunotherapies on vaccine development.
Main Results:
- Breast cancer vaccines have demonstrated the ability to induce T-cell responses.
- Clinical response rates to current breast cancer vaccines have been modest.
- Valuable knowledge regarding tumor immunology has been acquired.
Conclusions:
- Despite modest clinical responses, breast cancer vaccines provide crucial insights into tumor immunology.
- Emerging immunotherapies are creating renewed optimism for effective breast cancer vaccine development.
- Further research is essential to enhance the efficacy of breast cancer vaccines.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Gene Therapy
Group Therapy

